Eris Lifesciences Ltd (Eris) is a pharmaceutical company. It develops, manufactures and supplies pharmaceutical formulations to treat chronic and sub-chronic diseases. The company product portfolio includes tablets, capsules, sprays, syrups, drops, powder, injections, cookies, ointments and soft gels to treat pain, diabetes, cardiovascular, gynic, respiratory, neuroscience and gastrointestinal disorders. Eris offers vitamins, minerals and nutrition formulations. The company markets its products under Alerfix, Atorsave F, Axunil, Carpela, Citelec, DeepSenz, Obicure, Glimisave, Tendia, Cyblex, Zomelis, Otogesic, Raricap, Recontrex and other brands. It supplies its products through a network of distributors and chemist outlets across India. The company operates a manufacturing facility in Guwahati, Assam, India. Eris is headquartered in Ahmedabad, Gujarat, India.
Headquarters
India
Address
Shivarth Ambit, Plot No 142/2, Ramdas Road Off SBR, Near Swati Bungalows, Bodakdev, Ahmedabad, Gujarat, 380054
Website
www.eris.co.in
Telephone
91 79 30451111
No of Employees
3,548
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
ERIS (NSE)
Revenue (2022)
$214.8M
25.1%
(2022 vs 2021)
EPS
XYZ
Net Income (2022)
XYZ
-5.9%
(2022 vs 2021)
Market Cap*
$1.4B
Net Profit Margin (2022)
XYZ
-24.8%
(2022 vs 2021)
* As of and is in US$
Eris Lifesciences Ltd premium industry data and analytics
Products and Services
| Products | Services | Brands |
|---|---|---|
| Cardiovascular Drugs | Antidiabetic Solutions | Ticasave |
| Gastrointestinal Drugs | Pain Management | Eritel |
| Nutrition Products | Neuroscience Formulations | Olmin |
| XYZ | XYZ | |
| XYZ | XYZ | |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2024 | Contracts/Agreements | In March, the company entered into an agreement to acquire Indian branded formulations businesses from Biocon Biologics for US$150 million. |
| 2024 | Acquisitions/Mergers/Takeovers | In February, the company acquired a 51% stake in Swiss Parenterals Ltd. |
| 2023 | Contracts/Agreements | In November, the company entered into an agreement to acquire the nephrology and dermatology segments of Biocon Biologics Ltd. |
Competitor Comparison
| Key Parameters | Eris Lifesciences Ltd | Aurobindo Pharma Ltd | Alembic Pharmaceuticals Ltd | GlaxoSmithKline Pharmaceuticals Ltd | Suven Pharmaceuticals Ltd |
|---|---|---|---|---|---|
| Headquarters | India | India | India | India | India |
| City | Ahmedabad | Hyderabad | Vadodara | Mumbai | Hyderabad |
| State/Province | Gujarat | Telangana | Gujarat | Maharashtra | Telangana |
| No. of Employees | 3,548 | 15,690 | 14,593 | 3,680 | 1,165 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Amit Bakshi | Chairman; Managing Director | Executive Board | - | - |
| Sachin Shah | Chief Financial Officer; Director | Executive Board | - | - |
| Krishnakumar Vaidyanathan | Director; Chief Operating Officer | Executive Board | - | - |
| Inderjeet Singh Negi | Director; Director - Executive | Executive Board | - | - |
| Kaushal Kamlesh Shah | Director - Executive; Director | Executive Board | - | - |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward